Invests in
Sectors:
Locations:
Min Investment:
$100,000.00Max Investment:
$5,000,000.00Target Investment:
$1,500,000.00
Skills
Lists including Zack
Investments
Work Experience
2015
Managing Partner and co-founder
2015
JAZZ Venture Partners invests human performance technology - emerging companies leveraging the convergence of new digital technology platforms with recent advances in neuroscience that are creating entirely new ways to improve the human experience. These companies are impacting multiple $100B+ industries including health, wellness, learning, training, enterprise, sports and entertainment.
Executive Producer & Founder
2013 - 2017
The world's leading event where the mind and body meet game play.
2011 - 2016
Chairman
2015 - 2016
NIO is the trade association representing companies involved in neuroscience, brain research institutes and patient advocacy groups.
Executive Director & Founder
2011 - 2015
NIO is the trade association representing companies involved in neuroscience, brain research institutes and patient advocacy groups.
2006 - 2016
Leadership Board Member
2006 - 2016
The McGovern Institute for Brain Research at MIT is led by a team of world-renowned neuroscientists committed to meeting two great challenges of modern science: understanding how the brain works and discovering new ways to prevent or treat brain disorders.
2014 - 2015
Advisor
2014 - 2015
2010 - 2013
CEO and Founder
2010 - 2013
HealthRally is a neurosoftware company focused on wellness motivation.
2009 - 2010
Published Author
2009 - 2010
I am the author of The Neuro Revolution: How Brain Science Is Changing Our World. The hard cover book was originally published by St. Martin's Press on July 20, 2009 and was later reprinted in soft cover in the U.S. where it became a best seller. It has since been translated into Japanese, Korean, Chinese and Portuguese.
2003 - 2010
Managing Director & Co-founder
2003 - 2010
NeuroInsights is a research and advisory firm that provides in-depth analysis of the neurotechnology industry. Our mission is to accelerate the flow of capital to neurotechnology ventures by clarifying emerging market opportunities and risks.
2001 - 2002
VP Marketing
2001 - 2002
1996 - 2000
VP Marketing
1996 - 2000